These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7387139)

  • 1. Isoniazid interaction with tyrosine as a possible mode of action of the drug in mycobacteria.
    Herman RP; Weber MM
    Antimicrob Agents Chemother; 1980 Feb; 17(2):170-8. PubMed ID: 7387139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of isoniazid on growth inhibition and competition for an oxidized nicotinamide adenine dinucleotide regulatory site on the electron transport pathway in Mycobacterium phlei.
    Davis WB; Weber MM
    Antimicrob Agents Chemother; 1977 Aug; 12(2):213-8. PubMed ID: 197885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site of action of isoniazid on the electron transport chain and its relationship to nicotinamide adenine dinucleotide regulation in Mycobacterium phlei.
    Herman RP; Weber MM
    Antimicrob Agents Chemother; 1980 Mar; 17(3):450-4. PubMed ID: 7425605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a nicotinamide adenine dinucleotide glycohydrolase and an associated inhibitor in isoniazid-susceptible and -resistant Mycobacterium phlei.
    Davis WB
    Antimicrob Agents Chemother; 1980 Apr; 17(4):663-8. PubMed ID: 6249194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of catalases in Mycobacterium phlei on the basis of susceptibility to isoniazid: association with peroxidase and acquired resistance to isoniazid.
    Davis WB; Phillips DM
    Antimicrob Agents Chemother; 1977 Oct; 12(4):529-33. PubMed ID: 921249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered NADH/NAD+ ratio mediates coresistance to isoniazid and ethionamide in mycobacteria.
    Vilchèze C; Weisbrod TR; Chen B; Kremer L; Hazbón MH; Wang F; Alland D; Sacchettini JC; Jacobs WR
    Antimicrob Agents Chemother; 2005 Feb; 49(2):708-20. PubMed ID: 15673755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Sensitivity of Mycobacteria to Isoniazid Is Related to Differences in KatG-Mediated Enzymatic Activation of the Drug.
    Reingewertz TH; Meyer T; McIntosh F; Sullivan J; Meir M; Chang YF; Behr MA; Barkan D
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of mechanism of interaction of truncated isoniazid-nicotinamide adenine dinucleotide adduct against multiple enzymes of Mycobacterium tuberculosis by a computational approach.
    Jena L; Deshmukh S; Waghmare P; Kumar S; Harinath BC
    Int J Mycobacteriol; 2015 Dec; 4(4):276-83. PubMed ID: 26964808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of isoniazid on ultrastructure of Mycobacterium aurum and Mycobacterium tuberculosis and on production of secreted proteins.
    Bardou F; Quémard A; Dupont MA; Horn C; Marchal G; Daffé M
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2459-67. PubMed ID: 8913447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallographic studies on the binding of isonicotinyl-NAD adduct to wild-type and isoniazid resistant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis.
    Dias MV; Vasconcelos IB; Prado AM; Fadel V; Basso LA; de Azevedo WF; Santos DS
    J Struct Biol; 2007 Sep; 159(3):369-80. PubMed ID: 17588773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystallographic and pre-steady-state kinetics studies on binding of NADH to wild-type and isoniazid-resistant enoyl-ACP(CoA) reductase enzymes from Mycobacterium tuberculosis.
    Oliveira JS; Pereira JH; Canduri F; Rodrigues NC; de Souza ON; de Azevedo WF; Basso LA; Santos DS
    J Mol Biol; 2006 Jun; 359(3):646-66. PubMed ID: 16647717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoniazid Bactericidal Activity Involves Electron Transport Chain Perturbation.
    Zeng S; Soetaert K; Ravon F; Vandeput M; Bald D; Kauffmann JM; Mathys V; Wattiez R; Fontaine V
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis.
    Larsen MH; Vilchèze C; Kremer L; Besra GS; Parsons L; Salfinger M; Heifets L; Hazbon MH; Alland D; Sacchettini JC; Jacobs WR
    Mol Microbiol; 2002 Oct; 46(2):453-66. PubMed ID: 12406221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nicotinamide adenine dinucleotide on the membrane-associated reduced nicotinamide adenine dinucleotide oxidase of Mycobacterium phlei.
    Davis WB; Zlotnick BJ; Weber MM
    J Biol Chem; 1975 Mar; 250(5):1648-54. PubMed ID: 234463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoniazid inhibition of mycolic acid synthesis by cell extracts of sensitive and resistant strains of Mycobacterium aurum.
    Quémard A; Lacave C; Lanéelle G
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1035-9. PubMed ID: 1656850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mn(III) pyrophosphate as an efficient tool for studying the mode of action of isoniazid on the InhA protein of Mycobacterium tuberculosis.
    Nguyen M; Quémard A; Broussy S; Bernadou J; Meunier B
    Antimicrob Agents Chemother; 2002 Jul; 46(7):2137-44. PubMed ID: 12069966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transamination processes in mycobacteria with different biological properties].
    Fadeeva NI; Golyshevskaia VI; Bibergal' EA; Safonova SG
    Probl Tuberk; 1990; (9):62-4. PubMed ID: 2274513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NADH dehydrogenase defects confer isoniazid resistance and conditional lethality in Mycobacterium smegmatis.
    Miesel L; Weisbrod TR; Marcinkeviciene JA; Bittman R; Jacobs WR
    J Bacteriol; 1998 May; 180(9):2459-67. PubMed ID: 9573199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophil peroxidase oxidizes isoniazid to form the active metabolite against M. tuberculosis, isoniazid-NAD
    Babu D; Morgan AG; Reiz B; Whittal RM; Almas S; Lacy P; Siraki AG
    Chem Biol Interact; 2019 May; 305():48-53. PubMed ID: 30922765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On differences in oxygen consumption of proliferating INH-sensitive and INH-resistant cells of Mycobacterium phlei in the oxidative assimilation of various substrates].
    IWAINSKY H; KAEPPLER W
    Zentralbl Bakteriol; 1959 Dec; 176():521-9. PubMed ID: 13853059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.